Evidence map›Paper›PMID 33744903›Full record

ArticleDermatology (Basel, Switzerland)2021

Implementing Medical Chatbots: An Application on Hidradenitis Suppurativa.

Manuel Walss, Florian Anzengruber, Ahmed Arafa, Vahid Djamei, Alexander A Navarini

Abstract read
In one paragraph

Article in Dermatology (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Perspectives on Telemedicine during the Era of COVID-19; What Can Saudi Arabia Do?International journal of environmental research and public health · 2021
    Review
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Manuel WalssDepartment of Medicine, University of Zurich, Zurich, Switzerland.
Florian AnzengruberDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland.
Ahmed ArafaDepartment of Public Health, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt.
Vahid DjameiSwiss4ward, Zurich, Switzerland.
Alexander A NavariniDepartment of Dermatology, University Hospital Zurich, Zurich, Switzerland, alexander.navarini@usb.ch.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe use of digital health resources is growing quickly as they are easily accessible and permit self-evaluation. Yet, research on consumer health informatics platforms is insufficient. Chatbots, interactive conversational platforms based on artificial intelligence, can facilitate access to specific information. Hidradenitis suppurativa (HS) is burdensome and has a high threshold for consultation.

objectivesWe aimed to identify the most important principles for the assembly of medical chatbots through the analysis of usage data.

methodsThe HS Chatbot<A51_FootRef>1</A51_FootRef> is a question-and-answer platform in the style of a chatbot. Usage data were collected over the course of a year. 254 responses were statistically analysed.

results239 users were alleged patients. 82.9% were looking for a tentative diagnosis. The users were on average 32.49 (±11.33) years old and predominantly female (70.2%). The average number of clicks per visit on the website was 14.69 (±8.83).

conclusionsA medical chatbot has to be customised to the specific subject whilst general principles have to be considered. High-quality information has to be available in just a few clicks. People concerned about HS are looking for a diagnosis online and often have not seen a doctor previously. Guidance towards appropriate care should be provided.

Indexed as

Artificial IntelligenceCommunicationTelemedicineAdultFemaleHidradenitis SuppurativaHumansMalePatient Acceptance of Health CareYoung AdultChatbotDigital healthHidradenitis suppurativaTentative diagnosis

Identifiers

PMID33744903
PMCPMC8491464

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.